Ruth Chepngetich, the marathon world record-holder, has been provisionally suspended by the Athletics Integrity Unit (AIU) for a doping violation. On March 14, a urine sample collected from Chepngetich contained Hydrochlorothiazide (HCTZ), a diuretic banned by the World Anti Doping Agency (WADA).
What happened?
The sample was taken five days after Chepngetich finished second in the Lisbon Half Marathon with a time of 1 hour, six minutes, 20 seconds. The AIU reported that the result was an estimated 3800 ng/mL, exceeding the threshold for a positive test of 20ng/mL.
The Athletics Integrity Unit interviewed Chepngetich in person on April 16. She was cooperative and opted for a voluntary provisional suspension on April 19 while the investigation was ongoing.
Why it matters for Ruth Chepngetich
Chepngetich is currently ranked eighth in the world for the women's marathon. She became the first woman to clock a sub-two hour, 10 minute time over the distance in Chicago last year, with a record time of 2:09:56.
Chepngetich was due to compete in the London Marathon in April but pulled out ahead of the event, citing that she was “not in the right place mentally or physically to race my best”.
What comes next?
Chepngetich has the right to have her case heard at a disciplinary tribunal. The 30-year-old marathoner's provisional suspension is a significant development in her career, given her recent achievements in the sport.
The use of HCTZ can mask the presence of other banned substances. Chepngetich's high levels of HCTZ in her urine sample led to the provisional suspension, which may impact her future participation in marathon events.
The Athletics Integrity Unit's decision to suspend Chepngetich provisionally is based on the evidence collected from her urine sample. The investigation is ongoing, and Chepngetich's case will be heard at a disciplinary tribunal.
Chepngetich's performance in the Lisbon Half Marathon and her subsequent suspension have raised questions about her career and future in the sport. The outcome of the disciplinary tribunal will determine the next steps for the marathon world record-holder.
The World Anti Doping Agency's banned list includes HCTZ, which is used clinically to treat fluid retention. Chepngetich's case highlights the importance of adhering to anti-doping regulations in athletics.
The provisional suspension of Chepngetich is a significant development in the world of athletics. The outcome of her case will be closely watched by fans and athletes alike, given her achievements in the sport.